The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA)

Photodiagnosis and Photodynamic Therapy

Volumn 13, Issue , 2016, Pages 91-96

  Inoue, Keiji ^a   Matsuyama, Hideyasu ^b   Fujimoto, Kiyohide ^c   Hirao, Yoshihiko ^c   Watanabe, Hironobu ^d   Ozono, Seiichiro ^e   Oyama, Masafumi ^f   Ueno, Munehisa ^f   Sugimura, Yoshiki ^g   Shiina, Hiroaki ^h   Mimata, Hiromitsu ⁱ   Azuma, Haruhito ^j   Nagase, Yasushi ^k   Matsubara, Akio ^l   Ito, Yoichi M ^m   Shuin, Taro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d National Hospital Organization Kochi National Hospital   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^g MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

ⁱ OITA UNIVERSITY   (Japan)

^j OSAKA MEDICAL COLLEGE   (Japan)

^k TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^l HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^m HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

5 Aminolevulinic acid (5 ALA); Carcinoma in situ (CIS); Non muscle invasive bladder cancer (NMIBC); Photodynamic diagnosis (PDD); The advanced medical technology

Indexed keywords

AMINOLEVULINIC ACID; AMYLASE; CONTRAST MEDIUM; PHOTOSENSITIZING AGENT;

AORTA VALVE STENOSIS; ARTICLE; BLADDER PERFORATION; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; FLUORESCENCE; GOOD CLINICAL PRACTICE; HEART INFARCTION; HEMATURIA; HUMAN; HYPERAMYLASEMIA; HYPERBILIRUBINEMIA; HYPOCHLOREMIA; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NON MUSCLE INVASIVE BLADDER CANCER; PHOTODYNAMIC THERAPY; POLLAKISURIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; VOMITING; ADULT; ADVERSE EFFECTS; AGED; CLINICAL TRIAL; COMPUTER ASSISTED SURGERY; DIAGNOSTIC IMAGING; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; JAPAN; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; PROCEDURES; SMOOTH MUSCLE; TREATMENT OUTCOME; TUMOR INVASION; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CONTRAST MEDIA; CYSTOSCOPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; JAPAN; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; PHOTOSENSITIZING AGENTS; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84960532401     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2015.12.011     Document Type: Article

References (12)

1. Chopin D.K., Gattegno B. Superficial bladder tumors. Eur. Urol. 2002, 42:533-541.
2. Sylvester R.J., van der Meijden A.P., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 2006, 49:466-477.
3. Malik Z., Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br. J. Cancer 1987, 56:589-595.
4. Steinbach P., Weingandt H., Baumgartner R., et al. Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid. Photochem. Photobiol. 1995, 62:887-895.
5. Kausch I., Sommerauer M., Montorsi F., et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur. Urol. 2010, 57:595-606.
6. Rink M., Babjuk M., Catto J.W., et al. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur. Urol. 2013, 64:624-638.
7. Burger M., Grossman H.B., Droller M., et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur. Urol. 2013, 64:846-854.
8. Mowatt G., N'Dow J., Vale L., Aberdeen Technology Assessment Review (TAR) Group, et al. Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis. Int. J. Technol. Assess. Health Care 2011, 27:3-10.
9. Stummer W., Pichlmeier U., Meinel T., et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006, 7:392-401.
10. Inoue K., Fukuhara H., Shimamoto T., et al. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer. Cancer 2012, 118:1062-1074.
11. Inoue K., Anai S., Fujimoto K., et al. Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: a randomized, double-blind, multicentre phase II/III study. Photodiagn. Photodyn. Ther. 2015, 12:193-200.
12. Popken G., Schultze-Seemann W., Seiler K.U., Birkel M., Wetterauer U. Intravesical administration of 5-aminolevulinic acid (5-ALA): safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX. Eur. J. Clin. Pharmacol. 2000, 56:241-246.